{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:42:24Z","timestamp":1790664144238,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ4\/01760"],"award-info":[{"award-number":["2019\/33\/B\/NZ4\/01760"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/29\/B\/NZ4\/0071"],"award-info":[{"award-number":["2018\/29\/B\/NZ4\/0071"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/B\/NZ5\/00573"],"award-info":[{"award-number":["2016\/23\/B\/NZ5\/00573"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/17\/D\/NZ5\/03444"],"award-info":[{"award-number":["2015\/17\/D\/NZ5\/03444"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17GRNT32910002"],"award-info":[{"award-number":["17GRNT32910002"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>High-density lipoprotein (HDL), in addition to promoting reverse cholesterol transport, possesses anti-inflammatory, antioxidative, and antithrombotic activities. Paraoxonase 1 (PON1), carried on HDL in the blood, can contribute to these antiatherogenic activities. The PON1-Q192R polymorphism involves a change from glutamine (Q variant) to arginine (R variant) at position 192 of the PON1 protein and affects its enzymatic activity. The molecular basis of PON1 association with cardiovascular and neurological diseases is not fully understood. To get insight into the function of PON1 in human disease, we examined how genetic attenuation of PON1 levels\/activity affect plasma proteomes of mice and humans. Healthy participants (48.9 years old, 50% women) were randomly recruited from the Pozna\u0144 population. Four-month-old Pon1\u2212\/\u2212 (n = 17) and Pon1+\/+ (n = 8) mice (50% female) were used in these experiments. Plasma proteomes were analyzed using label-free mass spectrometry. Bioinformatics analysis was carried out using the Ingenuity Pathway Analysis (IPA) resources. PON1-Q192R polymorphism and Pon1\u2212\/\u2212 genotype induced similar changes in plasma proteomes of humans and mice, respectively. The top molecular network, identified by IPA, affected by these changes involved proteins participating in lipoprotein metabolism. Other PON1 genotype-dependent proteomic changes affect different biological networks in humans and mice: \u201ccardiovascular, neurological disease, organismal injury\/abnormalities\u201d in PON1-192QQ humans and \u201chumoral immune response, inflammatory response, protein synthesis\u201d and \u201ccell-to-cell signaling\/interaction, hematological system development\/function, immune cell trafficking\u201d in Pon1\u2212\/\u2212 mice. Our findings suggest that PON1 interacts with molecular pathways involved in lipoprotein metabolism, acute\/inflammatory response, and complement\/blood coagulation that are essential for blood homeostasis. Modulation of those interactions by the PON1 genotype can account for its association with cardiovascular and neurological diseases.<\/jats:p>","DOI":"10.3390\/antiox9121198","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T21:00:57Z","timestamp":1606683657000},"page":"1198","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genetic Attenuation of Paraoxonase 1 Activity Induces Proatherogenic Changes in Plasma Proteomes of Mice and Humans"],"prefix":"10.3390","volume":"9","author":[{"given":"Marta","family":"Sikora","sequence":"first","affiliation":[{"name":"European Centre for Bioinformatics and Genomics, Institute of Bioorganic Chemistry, 61-704 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-2960","authenticated-orcid":false,"given":"Ewa","family":"Bretes","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biotechnology, Pozna\u0144 University of Life Sciences, 60-632 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0791-5057","authenticated-orcid":false,"given":"Joanna","family":"Per\u0142a-Kaj\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biotechnology, Pozna\u0144 University of Life Sciences, 60-632 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Lewandowska","sequence":"additional","affiliation":[{"name":"European Centre for Bioinformatics and Genomics, Institute of Bioorganic Chemistry, 61-704 Pozna\u0144, Poland"},{"name":"International Center for Public Health, Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Marczak","sequence":"additional","affiliation":[{"name":"European Centre for Bioinformatics and Genomics, Institute of Bioorganic Chemistry, 61-704 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5845-4409","authenticated-orcid":false,"given":"Hieronim","family":"Jakubowski","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biotechnology, Pozna\u0144 University of Life Sciences, 60-632 Pozna\u0144, Poland"},{"name":"International Center for Public Health, Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.freeradbiomed.2004.07.034","article-title":"Paraoxonase 1 and atherosclerosis: Is the gene or the protein more important?","volume":"37","author":"Mackness","year":"2004","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"473480","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and Atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.med.54.101601.152421","article-title":"Functional genomic of the paraoxonase (PON1) polymorphisms: Effects on pesticide sensitivity, cardiovascular disease, and drug metabolism","volume":"54","author":"Costa","year":"2003","journal-title":"Annu. Rev. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCGENETICS.108.837179","article-title":"Paraoxonase and coronary heart disease risk: Language misleads, linkage misinforms, function clarifies","volume":"1","author":"Loscalzo","year":"2008","journal-title":"Circ. Cardiovasc Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1152\/physrev.00003.2018","article-title":"Homocysteine Modification in Protein Structure\/Function and Human Disease","volume":"99","author":"Jakubowski","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/joim.12834","article-title":"Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: The WENBIT trial","volume":"285","author":"Borowczyk","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_9","first-page":"6019","article-title":"Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans","volume":"32","author":"Borowczyk","year":"2018","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_10","first-page":"885","article-title":"Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans","volume":"50","author":"Lacinski","year":"2004","journal-title":"Cell. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(01)02143-3","article-title":"Genetic determinants of homocysteine thiolactonase activity in humans: Implications for atherosclerosis","volume":"491","author":"Jakubowski","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"ref_13","first-page":"284","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nat. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","article-title":"Combined Serum Paraoxonase Knockout\/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity with Systemic Oxidative Stress and Cardiovascular Risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2015.12.021","article-title":"Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies","volume":"245","author":"Kunutsor","year":"2016","journal-title":"Atheroscler."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1179\/1351000213Y.0000000071","article-title":"Paraoxonase 1 in neurological disorders","volume":"19","author":"Menini","year":"2014","journal-title":"Redox Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2007.3","article-title":"Candidate Single-Nucleotide Polymorphisms from a Genomewide Association Study of Alzheimer Disease","volume":"65","author":"Li","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1015.e7","DOI":"10.1016\/j.neurobiolaging.2010.08.003","article-title":"Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease","volume":"33","author":"Erlich","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5114\/fn.2013.35953","article-title":"Original article Paraoxonase 1 (PON1) gene -108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia","volume":"2","author":"Krzywkowski","year":"2013","journal-title":"Folia Neuropathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-2012-111940","article-title":"Metabolism and Neurotoxicity of Homocysteine Thiolactone in Mice: Evidence for a Protective Role of Paraoxonase 1","volume":"30","author":"Borowczyk","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","article-title":"The molecular basis of the human serum paraoxonase activity polymorphism","volume":"3","author":"Humbert","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_24","first-page":"931","article-title":"Paraoxonase 1 protects against protein N-homocysteinylation in humans","volume":"24","author":"Jakubowski","year":"2010","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1038\/s41598-020-67672-5","article-title":"Cystathionine \u03b2-synthase deficiency: Different changes in proteomes of thrombosis-resistant Cbs\u2212\/\u2212 mice and thrombosis-prone CBS\u2212\/\u2212 humans","volume":"10","author":"Sikora","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1474-9726.2008.00395.x","article-title":"Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress","volume":"7","author":"Ganfornina","year":"2008","journal-title":"Aging Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","article-title":"Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL","volume":"221","author":"Christoffersen","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1160\/TH11-10-0708","article-title":"Two missense mutations identified in venous thrombosis patients impair the inhibitory function of the protein Z dependent protease inhibitor","volume":"107","author":"Birch","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: A Coagulation Factor with Multiple Plasmatic and Cellular Functions","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2007-08-110254","article-title":"Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke","volume":"111","author":"Pruissen","year":"2008","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/ATVBAHA.112.253930","article-title":"Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities with Cardiovascular Risk","volume":"32","author":"Tang","year":"2012","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1160\/TH15-05-0410","article-title":"Genetics of Venous Thrombosis: Update in 2015","volume":"114","author":"Suchon","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.117.309207","article-title":"RXR Ligands Negatively Regulate Thrombosis and Hemostasis","volume":"37","author":"Unsworth","year":"2017","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ymgme.2014.07.011","article-title":"Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease","volume":"113","author":"Sikora","year":"2014","journal-title":"Mol. Genet. Metab."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/12\/1198\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:38:55Z","timestamp":1760179135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/12\/1198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["antiox9121198"],"URL":"https:\/\/doi.org\/10.3390\/antiox9121198","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}